Found 1 articles for: "JAK Inhibitor Safety"

JAK Inhibitor Safety Compared to Traditional Systemic Immunosuppressive Therapies

December 2022 | Volume 21 | Issue 12 | Original Article | 1298 | Copyright © December 2022

Dermatologists treating atopic dermatitis are interested in the safety profile of the recently available JAK inhibitors, upadacitinib and abrocitinib, especially after they received boxed safety warni...
Read More